REGENOCELL THERAPEUTICS, INC. Financing Cash Flow
REGENOCELL THERAPEUTICS, INC. reported Financing Cash Flow of $252.57 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-05-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-05-25
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2011-12-31 was $230.74K, a 353.02% increase year-over-year.
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2011-09-30 was $452.26K, a 678.76% increase year-over-year.
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2010-12-31 was $50.93K.
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2010-09-30 was $58.08K.
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2011 was $252.57K, a 11.12% increase from fiscal 2010.
- REGENOCELL THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2010 was $227.28K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2011-12-31 | $230.74K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | $683.00K derived: sum of 2 quarters · filed 2012-05-25 | $252.57K 10-K · filed 2012-05-25 | |
| 2011-09-30 | $452.26K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $21.83K 10-Q · filed 2011-11-21 | ||
| 2011-06-30 | -$430.44K 10-Q/A · filed 2011-09-01 | |||
| 2010-12-31 | $50.93K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | $109.01K derived: sum of 2 quarters · filed 2012-05-25 | $227.28K 10-K · filed 2012-05-25 | |
| 2010-09-30 | $58.08K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $176.35K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $118.27K 10-Q/A · filed 2011-09-01 |